Dr. Diane M. Ignar is a distinguished pharmaceutical executive and strategic advisor with over 25 years of comprehensive experience spanning the complete biopharmaceutical value chain from discovery research through commercialization. Her extensive expertise encompasses therapeutic development, business partnerships, emerging markets strategy, and technology innovation across multiple therapeutic areas including neuropharmacology, metabolic diseases, respiratory and allergic diseases, rare diseases, and oncology.